A Texas court of appeals recently ruled that Zimmer’s specialized instruments are exempt from sales and use taxes under the current tax code, according to a Ryan news release.
Texas Court Rules Zimmer’s Implant-Specific Instruments Fall Under Tax Exemption
Posted By
Josh Sandberg has been recruiting specifically in the musculoskeletal industry for over 8 years. Throughout this time, he has been able to have a positive impact on his client’s businesses. With an educational background in Business Management, Josh is adept to discern which people will be the best fit for the company he is searching for by understanding how candidates will incorporate with the company’s culture and operational nuances. His experience as an executive in a start-up business has granted him the ability to understand what is takes to thrive in a hands–on environment, where desire and dedication are paramount for success.
Related Posts
Zimmer Announces Quarterly Dividend for Second Quarter of 2013
WARSAW, Ind., June 14, 2013 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal care, today announced that its
Integra LifeSciences Reports First Quarter 2013 Financial Results
PLAINSBORO, N.J., May 2, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (IART) today reported its financial results for the
Where Has All the Medtech Venture Capital Gone?
Venture capital (VC) funding in the biotechnology and medical device sectors fell in 2012, dropping 14% in dollars and 7%
-
Globus Medical Announces Jury Verdict in Patent Infringement Lawsuit
-
Osseon® Therapeutics Announces Another VCF Product
-
The Impact of Business Strategy and the FDA on the Future of Spine Surgery
-
MiMedx Is Issued Three New U.S. Patents For Placental Tissue Allografts
-
Zimmer Announces Quarterly Dividend for Second Quarter of 2013
510k
2009
aaos
acquire
acquisition
Alphatec
analyst
Appointment
beckers
Biomet
CE Mark
ceo
DePuy
FDA
featured
financial results
financing
funding
growth
healthcare reform
hip
hire
Integra
JNJ
Knee
kyphoplasty
litigation
mdt
medtronic
milestone
NuVasive
orthofix
patent
pictures
Product Launch
raised
snn
Spine
Stem Cell
Stryker
Synthes
trans1
vcf
vertebroplasty
Zimmer



Friedrich Tieber: I am not surprised, that Medtronic act´s in this kind. They paid a lot...
mosm: a very good post.. thanks for uploading......
Puksatawny Phil: I guess if you can't get growth through new sales, you'll do whatever ...
Vinden: Revenue heading south so they have to make it up somewhere, why not go...
Josh Sandberg: I would love to get your input on this if you have any information. Pl...